Omkar Speciality Chemicals share news and announcements
BSE: 533317Chemicals & Petrochemicals
Trading suspended since 29 Apr 2026
Last traded ₹3.41 on 28 Apr 2026
Omkar Speciality Chemicals share news and announcements
1,242 announcements, routine notices left out, newest first. Page 19 of 25.
Nov 2014
13 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 13, 2014, inter alia, has discussed and approved the following : ....13 Nov · Board meeting
In the Board meeting of the Company held on November 13, 2014, the Board discussed and approved following - 1) Raising of funds upto an amount of Rs. 125 crores, by way of a qualified institutions placement, on such terms and conditions as may be decided by the Board of Directors and / or Committee of the Board, in accordance with the provisions of Chapter VIII of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and other applicable laws, subject to approval of the members of the Company through postal ballot. 2) Increase in Authorised Share Capital of the Company from Rs. 25 crores to Rs. 35 crores, subject to the approval of the Members of the Company through postal ballot.5 Nov · Board meeting
Inter-alia, to consider and approve the Un-audited Financial Results for the quarter ended on September 30, 2014 and to discuss about other matters as per the agenda of the meeting.
Oct 2014
29 Oct · Update on the grant of Patent to the Company
Company's claim for process patent for an Advance Intermediate namely "BENZENESELENINIC ANHYDRIDE”, having special applications ....23 Oct · Updates
Wholly owned subsidiary, M/s. Lasa Laboratory Private Limited, has been successful in obtaining the Certificate of Suitability from European Directorate for the Quality of Medicines & Healthcare (EDQM), vide certificate No. R0-CEP 2013-184-Rev 00 dated 15th October, 2014, for selling its product FENBENDAZOLE . This certificate will be useful for the Company in marketing its above product to regulatory customers in the European Market for Veterinary use.22 Oct · Update on receipt of Certificate of Suitability from EDQM, Europe
Wholly owned subsidiary, M/s. Lasa Laboratory Private Limited, has been successful in obtaining the Certificate of Suitability from ....21 Oct · Shareholding Pattern For September 30, 2014
13 Oct · Invitation to the Shareholders to visit plant located at Badlapur
Sep 2014
16 Sep · Update on the grant of Patent to the Company
Company's claim for process patent for an Advance Intermediate namely "5-IODO-2-METHYLBENZOIC ACID", having special applications ....10 Sep · Shareholding Pattern as on August 30, 2014
1 Sep · Board meeting
Board of Directors have granted their approval for issuance of 950000 Equity Shares of Rs. 10 each fully paid-up at a price Rs. 150 per share to the promoters and promoter group, pursuant to the conversion of Warrants issued by the Company, in accordance with the Securities and Exchange Board of India (Issue of capital and Disclosure Requirement ) Regulations, 2009 [ SEBI (ICDR) Regulations ] as amended from time to time.
Aug 2014
30 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 30, 2014, have granted their approval for issuance of 950,000 (Nine ....27 Aug · Board meeting
To Consider and approve the issuance of the Equity Share pursuant to conversion of Warrants issued by the Company, to the Promoter Group, and to discuss about other matters as per the agenda of the meeting. Further, as per SEBI ( Prohibition of Insider Trading Regulation ), 1992 and the Code of Conduct adopted by the Company, the 'Trading Window' for trading in the Company's securities shall remain closed for the Promoters, Directors and Designated Employees of the Company from August 27, 2014 till September 01, 2014 ( both days Inclusive ) for the aforesaid purpose.27 Aug · Board Meeting on August 30, 2014
Meeting of the Board of Directors of the Company will be held on August 30, 2014, to consider and approve the issuance of the Equity ....5 Aug · Board meeting
To consider and approve the Un-audited Financial Results for the Quarter ended on June 30, 2014 and to discuss about other matters as per the agenda of the meeting. Further, as per SEBI (Prohibition of Insider Trading Regulation), 1992 and the Code of Conduct adopted by the Company, the ' Trading Window ' for trading in the Company's securities shall remain closed for the Promoters, Directors and Designated Employees of the Company from August 5, 2014 till august 18, 2014 (both days inclusive) for the purpose of declaration of quarterly financial results.
Jul 2014